Levomepromazine vs Typical antipsychotics
Leaving the study early ‐ medium term ‐ any reason · patients with schizophrenia
It is very uncertain whether levomepromazine changes leaving the study early ‐ medium term ‐ any reason compared with typical antipsychotics (very low certainty).
1 finding from 1 review
- RR 2 [0.2, 19.62]1 study · 28 participantsVery low